Perrigo Company (PRGO) EVP Sharon Kochan Sells 318 Shares

Perrigo Company (NYSE:PRGO) EVP Sharon Kochan sold 318 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $81.36, for a total transaction of $25,872.48. Following the transaction, the executive vice president now owns 10,231 shares in the company, valued at $832,394.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Sharon Kochan also recently made the following trade(s):

  • On Thursday, August 31st, Sharon Kochan sold 1,500 shares of Perrigo stock. The stock was sold at an average price of $79.03, for a total transaction of $118,545.00.

Perrigo Company (PRGO) traded up 2.75% on Monday, reaching $85.07. 1,932,496 shares of the company’s stock traded hands. The stock has a 50-day moving average of $75.90 and a 200 day moving average of $72.95. The firm’s market capitalization is $12.13 billion. Perrigo Company has a 52 week low of $63.68 and a 52 week high of $99.14.

Perrigo (NYSE:PRGO) last posted its quarterly earnings data on Thursday, August 10th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.94 by $0.28. The company had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.18 billion. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. The business’s quarterly revenue was down 7.7% on a year-over-year basis. During the same quarter last year, the firm posted $1.93 earnings per share. On average, equities analysts expect that Perrigo Company will post $4.58 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Friday, August 25th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Wednesday, August 23rd. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.75%. Perrigo’s dividend payout ratio is currently -3.51%.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally published by Markets Daily and is owned by of Markets Daily. If you are accessing this piece of content on another publication, it was illegally copied and republished in violation of US and international copyright laws. The original version of this piece of content can be read at https://www.themarketsdaily.com/2017/09/12/perrigo-company-prgo-evp-sharon-kochan-sells-318-shares.html.

Institutional investors and hedge funds have recently bought and sold shares of the company. Credit Suisse AG raised its stake in shares of Perrigo by 13.8% during the first quarter. Credit Suisse AG now owns 241,688 shares of the company’s stock valued at $16,046,000 after purchasing an additional 29,375 shares during the period. Allen Investment Management LLC grew its position in shares of Perrigo by 7.1% during the second quarter. Allen Investment Management LLC now owns 7,143 shares of the company’s stock worth $539,000 after buying an additional 473 shares in the last quarter. Amalgamated Bank grew its position in shares of Perrigo by 6.0% during the first quarter. Amalgamated Bank now owns 9,759 shares of the company’s stock worth $648,000 after buying an additional 555 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp grew its position in shares of Perrigo by 32.5% during the second quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 54,530 shares of the company’s stock worth $4,118,000 after buying an additional 13,382 shares in the last quarter. Finally, LMR Partners LLP acquired a new stake in shares of Perrigo during the second quarter worth approximately $290,000. Institutional investors own 80.36% of the company’s stock.

A number of equities analysts recently weighed in on the stock. BidaskClub upgraded shares of Perrigo from a “strong sell” rating to a “sell” rating in a research report on Saturday. Jefferies Group LLC reaffirmed a “hold” rating and set a $71.00 target price (up from $69.00) on shares of Perrigo in a research note on Friday, August 11th. Stifel Nicolaus reaffirmed a “hold” rating on shares of Perrigo in a research note on Friday, August 11th. Oppenheimer Holdings, Inc. assumed coverage on shares of Perrigo in a research note on Thursday. They set an “outperform” rating and a $88.00 target price on the stock. Finally, CIBC assumed coverage on shares of Perrigo in a research note on Thursday. They set an “outperform” rating and a $88.00 target price on the stock. Two analysts have rated the stock with a sell rating, nine have given a hold rating and eight have assigned a buy rating to the company. Perrigo presently has an average rating of “Hold” and a consensus target price of $87.00.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.

Insider Buying and Selling by Quarter for Perrigo (NYSE:PRGO)

Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply